about
Efficient removal of platelets from peripheral blood progenitor cell products using a novel micro-chip based acoustophoretic platform.Bone marrow multipotent mesenchymal stroma cells act as pericyte-like migratory vehicles in experimental gliomasToward brain tumor gene therapy using multipotent mesenchymal stromal cell vectors.Approaches to dendritic cell-based immunotherapy after peripheral blood stem cell transplantation.Human embryonic stem cell-derived mesenchymal stroma cells (hES-MSCs) engraft in vivo and support hematopoiesis without suppressing immune function: implications for off-the shelf ES-MSC therapiesLow/negative expression of PDGFR-α identifies the candidate primary mesenchymal stromal cells in adult human bone marrow.CD146 expression on primary nonhematopoietic bone marrow stem cells is correlated with in situ localization.Regulation of advanced therapy medicinal products in Europe and the role of academia.Hematotoxic effects of benzene analyzed by mathematical modeling.High-dose iodine-131-metaiodobenzylguanidine with haploidentical stem cell transplantation and posttransplant immunotherapy in children with relapsed/refractory neuroblastoma.Ex vivo expansion of normal progenitor cells from acute myeloid leukemia cell-contaminated CD34+ peripheral blood progenitor cells after mafosfamide purging.Characterization of bone marrow-derived mesenchymal stromal cells (MSC) based on gene expression profiling of functionally defined MSC subsets.Peripheral blood cell telomere length measurements indicate that hematopoietic stem cell turnover is not significantly increased in whole blood and apheresis PLT donors.Self-renewing human bone marrow mesenspheres promote hematopoietic stem cell expansion.A mathematical approach to benzo[a]pyrene-induced hematotoxicity.Mesenchymal stem cell content of human vertebral bone marrow.Mesenchymal stromal cells from primary osteosarcoma are non-malignant and strikingly similar to their bone marrow counterparts.Side effects of AZT prophylaxis after occupational exposure to HIV-infected bloodClinical use for expanded peripheral blood stem cellsEffective ex vivo generation of granulopoietic postprogenitor cells from mobilized peripheral blood CD34(+) cellsHow many myeloid post-progenitor cells have to be transplanted to completely abrogate neutropenia after peripheral blood progenitor cell transplantation? Results of a computer simulationExpression of novel surface antigens on early hematopoietic cellsComparison of two leukapheresis programs for computerized collection of blood progenitor cells on a new cell separatorRapid and effective CD3 T-cell depletion with a magnetic cell sorting program to produce peripheral blood progenitor cell products for haploidentical transplantation in children and adultsLong-term results after transplantation of CD34+ selected (CellPro) versus unselected peripheral blood progenitor cells (PBPC) from related allogeneic donorsA novel immunohistochemical sequential multi-labelling and erasing technique enables epitope characterization of bone marrow pericytes in primary myelofibrosisEfficient purification of CD4+ lymphocytes from peripheral blood progenitor cell products using affinity bead acoustophoresisAffinity-Bead-Mediated Enrichment of CD8+ Lymphocytes from Peripheral Blood Progenitor Cell Products Using Acoustophoresis
P50
Q27325686-3A8FF417-B2DC-4226-AEDE-443184A65810Q33382708-2968CD37-2D59-45A5-8511-AB60547EEB6CQ33560685-E66034C2-1E7C-4DB2-A908-64C7C7D0F1CBQ33661936-895E881B-1F50-4FEF-8A66-FE41AE319A72Q34576397-DAE23DD8-EB13-4260-9418-1A14592DD909Q34684567-0BD7F4BF-8758-4202-96FF-F11ADB1DD281Q35029420-D0CBD6E0-6859-44D4-AACC-F1D8206B8DC3Q38151421-BAD1D388-2D05-46D4-B137-08C1B5C54ED6Q41118515-B4D8B881-6E4B-404C-8FCC-37780BB3F702Q43297419-45B4BC8C-89D3-4AE6-83D7-606DB82E727FQ43859030-1DF05D79-8ABE-449D-8BC9-E6A5FC76BE5CQ44041664-3487A0BD-610B-45D6-846A-BDBB12F9880DQ47752582-9A2CB6C3-77B0-46EF-AEA7-334F1BEF6965Q51036755-E0FF158A-9D25-46A3-ADB8-8ECD269BC4BCQ52433015-CED6182A-7171-4DC4-9951-C43AE79A37D6Q52942565-EF905D6D-A39C-43E7-8C83-9D4158894D65Q54647133-64A56C12-F0B5-4B1E-8110-60AF6971FD02Q72189937-5553AAE9-035D-4C3C-939A-95CEFCE7B307Q72990382-D8E92409-D243-4AF3-BDD8-C80732D2D4D1Q73713454-0BB0256D-E094-41C8-A4DA-74B611C2D520Q77787562-8D936256-EB71-4DD6-A09D-EE93516DB09BQ77891823-C34E595C-481A-4641-A285-2421EB43A696Q78766957-6CE4884A-9B1B-411D-B3CA-479DE7527959Q81492089-50E37D2B-49B6-43FE-B4EE-D4D4CB53A6AEQ83164539-481A2D15-FD94-430B-9E29-4B782D80AF1CQ83258186-6DFF2C4B-A922-4B15-9816-69FD519AD741Q87428770-99BE9F51-02C7-49A4-91A7-554D38DD228DQ92887856-BD382F47-575B-4724-BF0D-9DAC2078362E
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Stefan Scheding
@ast
Stefan Scheding
@en
Stefan Scheding
@es
Stefan Scheding
@nl
Stefan Scheding
@sl
type
label
Stefan Scheding
@ast
Stefan Scheding
@en
Stefan Scheding
@es
Stefan Scheding
@nl
Stefan Scheding
@sl
prefLabel
Stefan Scheding
@ast
Stefan Scheding
@en
Stefan Scheding
@es
Stefan Scheding
@nl
Stefan Scheding
@sl
P106
P1153
7004246548
P21
P31
P496
0000-0002-8005-9568